Research In Motion Ltd (BBRY): Who’s Shorting This Stock?

Page 1 of 2

Research In Motion Ltd (NASDAQ:BBRY) BlackBerry, is questionably one of the most debated stocks in the market. From the top executive being driven in a Rolls Royce in Wall Street to the small business owner in Main Street, the BlackBerry argument has managed to capture a compelling number. In all of this, bears and bulls have been divided in a fashion reminiscent of the infamous Berlin Wall. The raging war between these two extremes has raised concerns that there is more to fight for in Research In Motion Ltd (NASDAQ:BBRY) BlackBerry; not just some chic black handset, but money — big money.

Research In Motion LtdOver the past year, it has come out that the short interest in Research In Motion Ltd (NASDAQ:BBRY) BlackBerry has increased faster than a coalition of famished cheetahs hunting on the African Savannah. Reports relating to late April show that around 100 million shares were added short in the last 12 months; 40 million of which were added this year alone. Currently, around 164.69 million shares are shorted. This represents 33.3% of the total float; a tremendously huge number when compared to Apple Inc. (NASDAQ:AAPL)’s short interest which comes in at a paltry 2.4% of the total float.

Shorts want the share price to take a dive; something that has not happened as of yet. If anything, Research In Motion Ltd (NASDAQ:BBRY) BlackBerry’s stock has gained 25% this year, surpassing the 14% gain of the S&P. The tremendous short interest in BlackBerry explains all the suspect reports; most recently by Pacific Crest.

Pacific Crest versus Jefferies

In an early May report, Pacific Crest advanced a bearish case on Research In Motion Ltd (NASDAQ:BBRY) BlackBerry, citing lower-than-expected sales moving forward. The key highlight in the report was, however, not the lower than expected sales, but rather the expected production cutbacks. As a result of the report, BlackBerry’s share price dropped notably.

Pacific Crest used the last two months’ sales estimates to warrant its bearish stance. In each of the last two months, unit sales are estimated to have settled in the range of 1 million to 1.25 million units. Pacific Crest analyst James Faucette however ventured that Research In Motion Ltd (NASDAQ:BBRY) maintained production in the range of 1.5 million to 2 million units. Faucette added that BlackBerry would have to reduce production at some point in order to avoid a possible inventory glut.

After the bearish report, research firm Jefferies went ahead to publish a counter report. Jefferies’ Peter Misek argued that there was no evidence supporting the bearish case on BlackBerry. After conducting retail checks in the U.K and Canada, Misek affirmed that demand for both the Q10 and Z10 was high. He further added that the only possible cuts would be for the BlackBerry 7, which in turn could help margins.

This evident tag of war between the two research firms opened up a flurry of debate on multiple investment platforms. In each argument, however, the common thread that cut was the presence of overbearing short interest in Research In Motion Ltd (NASDAQ:BBRY).

U.S. case overdone

BlackBerry’s slow progress in the U.S. has been overdone. Some have even cast doom on BlackBerry, saying that Nokia Corporation (ADR) (NYSE:NOK), its fellow turnaround player, is making more progress in the U.S. Kantar World Panel argues that Windows Phone penetration in the U.S. outpaced Research In Motion Ltd (NASDAQ:BBRY). As noted in an article (here), BlackBerry’s U.S market share in the quarter ended March came in at a paltry 0.9% compared the Windows Phone’s (which is essentially Nokia) 5.6%. Nokia Corporation (ADR) (NYSE:NOK)’s Windows Phone commanded 3.2% of the U.S. smartphone market in January 2013, signaling a huge gain in just two months.

Page 1 of 2

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The Most Wanted Drug Lords

The Oldest Money Managers

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

The Best B-Boy Movies

Most Awesome Hip Hop Documentaries

Foods That Stain Your Teeth

Richest Doctors in the World

The Best Movie Sountracks Ever

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!